Large-scale testing (Phase 3)Study completedNCT05905055
What this trial is testing
P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
Who this might be right for
Complicated Urinary Tract InfectionAcute PyelonephritisHospital-acquired Bacterial Pneumonia+2 more
Meiji Seika Pharma Co., Ltd. 126